Desk›Healthcare› Corona Remedies Ltd
Corona Remedies Ltd
BSE 544644 · NSE CORONA · ISIN INE02ZQ01018 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹2,083.05
-0.20%
BSE close, 28 August 2026
₹12,739.95 cr
6.1 cr shares · Small cap
₹3,916.25 cr
as published
64.2× · —
EPS ₹32.46 · BV —
1,403.18 / 184.85
₹ cr, as filed
15
6 selected · 40%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -7.9% |
|---|---|
| Against 52-week low | +55.8% |
| Day change | -0.20% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹32.46 |
|---|---|
| Price / earnings | 64.17× |
| Price / book | — |
| Book value — derived, price ÷ P/B | — |
| Return on equity | — |
| Operating margin | 22.79% |
| Net margin | 14.23% |
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 422.43 | 60.10 | 9.83 | 22.79% | 14.23% |
| Mar-26 · Q | 353.09 | 45.05 | 7.37 | 18.73% | 12.76% |
| FY25-26 | 1,403.18 | 184.85 | 30.22 | 20.31% | 13.17% |
Quarter on quarter
- Revenue, quarter on quarter
- +19.6%
- Net profit, quarter on quarter
- +33.4%
- Operating margin, quarter on quarter
- +406 bps
Disclosure profile 15 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Credit Rating | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 6 |
| Procedural | |
| Analyst / Investor Meet | 5 |
| Clarification | 1 |
| Compliance Certificate | 1 |
| General | 1 |
| Trading Window | 1 |
| Procedural sub-total | 9 |
| Total | 15 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
15 filings · 6 selected · busiest 2026-07-31
Filing rhythm · the twelve most recent
2026-07-312026-10-05
SelectedProcedural
Filings
15 in the window · 20 earlier on record
-
5 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 September 2026 ·
-
28 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
18 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of participation in Analyst / Investor meet
Company Update / Analyst / Investor Meet View filing →
-
10 September 2026 ·
-
10 September 2026 ·
Clarification sought from Corona Remedies Ltd
The Exchange has sought clarification from Corona Remedies Ltd on September 10, 2026, with reference to Movement in Volume. The reply is awaited.
Company Update / Clarification
-
20 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of participation in Analyst / Investor Conference
Company Update / Analyst / Investor Meet View filing →
-
10 August 2026 ·
Earnings Call Transcript
Transcript of Earnings Call with Analyst / Investor on Unaudited Financial Results for the first quarter and three months ended June 30, 2026
Company Update / Earnings Call Transcript View filing →
-
10 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation for Schedule of Analysts / Investor Conference
Company Update / Analyst / Investor Meet View filing →
-
3 August 2026 ·
Analyst / Investor Meet - Outcome
Audio Recording of Q1 FY27 Earnings Conference Call with Analysts / Investors
Company Update / Analyst / Investor Meet View filing →
-
31 July 2026 ·
Investor Presentation
Analyst/Investor presentation
Company Update / Investor Presentation View filing →
-
31 July 2026 ·
Press Release / Media Release
Press Release on Financial Results for Q1FY27
Company Update / Press Release / Media Release View filing →
-
31 July 2026 ·
Unaudited Financial Results For The First Quarter And Three Months Ended June 30, 2026
Unaudited Financial Results for the first quarter and three months ended June 30, 2026
Result / Financial Results View filing →
-
31 July 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting
Board Meeting / Outcome of Board Meeting View filing →
-
22 July 2026 ·
Analyst / Investor Meet - Intimation
Intimation for Schedule of Analysts / Investor Conference
Company Update / Analyst / Investor Meet View filing →
RSS feed for Corona Remedies Ltd · the 50 most recent filings